Safety Shot, Inc. Files 8-K: Material Definitive Agreement
Ticker: BNKK · Form: 8-K · Filed: Dec 10, 2024 · CIK: 1760903
| Field | Detail |
|---|---|
| Company | Safety Shot, INC. (BNKK) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $8.50, $5,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-actions, filing
Related Tickers: SHOT
TL;DR
Safety Shot (SHOT) signed a big deal on Dec 6th, filing an 8-K. Details to follow.
AI Summary
On December 6, 2024, Safety Shot, Inc. entered into a Material Definitive Agreement. The company, formerly known as Jupiter Wellness, Inc. and CBD Brands, Inc., is incorporated in Delaware and operates in the perfumes and cosmetics sector. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates a significant new agreement for Safety Shot, Inc., which could impact its business operations and financial future.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce significant new risks or opportunities, requiring careful evaluation.
Key Numbers
- 001-39569 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- Safety Shot, Inc. (company) — Registrant
- December 6, 2024 (date) — Date of earliest event reported
- Jupiter Wellness, Inc. (company) — Former company name
- CBD Brands, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the Material Definitive Agreement?
The filing indicates the entry into a Material Definitive Agreement but does not specify the details of the agreement itself within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated December 6, 2024.
What were Safety Shot, Inc.'s previous company names?
Safety Shot, Inc. was formerly known as Jupiter Wellness, Inc. and CBD Brands, Inc.
In which state is Safety Shot, Inc. incorporated?
Safety Shot, Inc. is incorporated in Delaware.
What is the SIC code for Safety Shot, Inc.?
The Standard Industrial Classification (SIC) code for Safety Shot, Inc. is 2844, which corresponds to Perfumes, Cosmetics & Other Toilet Preparations.
Filing Stats: 1,058 words · 4 min read · ~4 pages · Grade level 14 · Accepted 2024-12-10 16:07:23
Key Financial Figures
- $8.50 — isable for one share of Common Stock at $8.50 per share SHOTW The Nasdaq Stock Ma
- $5,000,000 — ng an aggregate offering price of up to $5,000,000, subject to certain limitations on the
Filing Documents
- form8-k.htm (8-K) — 47KB
- ex5-1.htm (EX-5.1) — 15KB
- ex10-1.htm (EX-10.1) — 249KB
- 0001493152-24-049466.txt ( ) — 592KB
- shot-20241206.xsd (EX-101.SCH) — 4KB
- shot-20241206_def.xml (EX-101.DEF) — 29KB
- shot-20241206_lab.xml (EX-101.LAB) — 36KB
- shot-20241206_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024 SAFETY SHOT, INC. (Exact name of registrant as specified in charter) Delaware 001-39569 83-2455880 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1061 E. Indiantown Rd. , Ste. 110 , Jupiter , FL 33477 (Address of principal executive offices) (Zip Code) (561) 244-7100 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock SHOT The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Warrants, each exercisable for one share of Common Stock at $8.50 per share SHOTW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01. Entry into a Material Definitive Agreement On December 6, 2024, Safety Shot, Inc., (the "Company") entered into an Equity Disbursement Agreement (the "Sales Agreement") with Maxim Group LLC (the "Sales Agent") pursuant to which the Company may offer and sell, from time to time, in its sole discretion, shares of its common stock, having an aggregate offering price of up to $5,000,000, subject to certain limitations on the amount of common stock that may be offered and sold by the Company set forth in the Sales Agreement. The Company is not obligated to make any sales of common stock under the Sales Agreement and any determination by the Company to do so will be dependent, among other things, on market conditions and the Company's capital raising needs. Any shares offered and sold in the at-the-market offering will be issued pursuant to the registration statement on Form S-3 (File No. 333-267644), initially filed by the Company with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Securities Act"), on September 28, 2022, and declared effective on November 09, 2022, and the prospectus supplement relating to the at-the-market offering filed with the SEC on December 6, 2024, and any applicable additional prospectus supplements related to the at-the-market offering that form a part of the registration statement. The Sales Agent may sell the shares of common stock by any method deemed to be an "at the market offering" as defined in Rule 415(a)(4) of the Securities Act of 1933, as amended, including sales made through The Nasdaq Capital Market ("Nasdaq"), or any other trading market for the common stock, sales made to or through a market maker other than on an exchange or through an electronic communications network, or in negotiated transactions pursuant to terms set forth in a placement notice delivered by the Company to the Sales Agent under the Sales Agreement. Upon delivery of a placement notice and subject to the terms and conditions of the Sales Agreement, the Sales Agent will use commercially reasonable efforts, consistent with its normal trading and sales practices, applicable state and federal law, rules and regulations, and the rules of Nasdaq, to sell the shares from time to time based upon the Company's instructions, including any price, time or size limits specified by the Company. The Sales Agent are not obligated to purchase any shares of common stock on a principal basis pursuant to the Sales Agreement. The Company will pay the Sales Agent a commission equal to 3.0% of the gross sales proceeds of any shares sold through the Sales Agent under the Sales Agreement, and also has provided the Sales Agent with customary indemnification and con